Publisher: Icon Group International, Inc.
Category: Oncology/Hematology

Oncology/Hematology market research reports by Icon Group International, Inc.

(361 reports matching your criteria)
    • The 2023-2028 World Outlook for Thoracotomy Lung Cancer Surgeries

      The 2023-2028 World Outlook for Thoracotomy Lung Cancer Surgeries This study covers the world outlook for thoracotomy lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2023-2028 World Outlook for Thyroid Cancer Drugs

      The 2023-2028 World Outlook for Thyroid Cancer Drugs This study covers the world outlook for thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2023-2028 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies

      The 2023-2028 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies This study covers the world outlook for oncolytic virotherapy cancer gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2023-2028 World Outlook for Breast Cancer Diagnostic and Drugs

      The 2023-2028 World Outlook for Breast Cancer Diagnostic and Drugs This study covers the world outlook for breast cancer diagnostic and drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2023-2028 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics

      The 2023-2028 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics This study covers the world outlook for acute lymphocytic-lymphoblastic leukemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More

    • The 2023-2028 World Outlook for Multiple Myeloma Therapeutics

      The 2023-2028 World Outlook for Multiple Myeloma Therapeutics This study covers the world outlook for multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2023-2028 World Outlook for Novel Drug Delivery Systems in Cancer Therapies

      The 2023-2028 World Outlook for Novel Drug Delivery Systems in Cancer Therapies This study covers the world outlook for novel drug delivery systems in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More

    • The 2023-2028 World Outlook for Cancer Biomarkers

      The 2023-2028 World Outlook for Cancer Biomarkers This study covers the world outlook for cancer biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2023-2028 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

      The 2023-2028 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2023-2028 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)

      The 2023-2028 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2023-2028 World Outlook for Cancer Cachexia

      The 2023-2028 World Outlook for Cancer Cachexia This study covers the world outlook for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2023-2028 World Outlook for Cancer Profiling Technologies

      The 2023-2028 World Outlook for Cancer Profiling Technologies This study covers the world outlook for cancer profiling technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2023-2028 World Outlook for Cancer Screenings

      The 2023-2028 World Outlook for Cancer Screenings This study covers the world outlook for cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2023-2028 World Outlook for Cancer Stem Cells

      The 2023-2028 World Outlook for Cancer Stem Cells This study covers the world outlook for cancer stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2023-2028 World Outlook for Non-Small Cell Lung Cancer Therapeutics

      The 2023-2028 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2023-2028 World Outlook for Central Nervous System Lymphoma

      The 2023-2028 World Outlook for Central Nervous System Lymphoma This study covers the world outlook for central nervous system lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2023-2028 World Outlook for Cervical Cancer Treatments

      The 2023-2028 World Outlook for Cervical Cancer Treatments This study covers the world outlook for cervical cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2023-2028 World Outlook for Alpha Emitters for Melanoma

      The 2023-2028 World Outlook for Alpha Emitters for Melanoma This study covers the world outlook for alpha emitters for melanoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2023-2028 World Outlook for Chronic Myelogenous Leukemia Treatments

      The 2023-2028 World Outlook for Chronic Myelogenous Leukemia Treatments This study covers the world outlook for chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2023-2028 World Outlook for Head and Neck Oncology Nutrition

      The 2023-2028 World Outlook for Head and Neck Oncology Nutrition This study covers the world outlook for head and neck oncology nutrition across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2023-2028 World Outlook for Cancer Diagnostics

      The 2023-2028 World Outlook for Cancer Diagnostics This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2023-2028 World Outlook for Cancer Supportive Care Products

      The 2023-2028 World Outlook for Cancer Supportive Care Products This study covers the world outlook for cancer supportive care products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2023-2028 World Outlook for Oncology Nutrition

      The 2023-2028 World Outlook for Oncology Nutrition This study covers the world outlook for oncology nutrition across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2023-2028 World Outlook for Cervical Cancer Diagnostics

      The 2023-2028 World Outlook for Cervical Cancer Diagnostics This study covers the world outlook for cervical cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2023-2028 World Outlook for Cervical Cancer Diagnostic Testing

      The 2023-2028 World Outlook for Cervical Cancer Diagnostic Testing This study covers the world outlook for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

5 6 7 8 9 10 11 12 13 14

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings